News & Analysis as of

Health Care Providers Today's Popular Updates Investors

Rivkin Radler LLP

Radiology Practice to Pay $8.9M to Resolve FCA/AKS Claims

Rivkin Radler LLP on

The U.S. Attorney’s Office for the Southern District of Texas announced on August 20 that National Interventional Radiology Partners PLLC (NIRP) and its founder and CEO will pay $8,884,091 to the United States to resolve...more

Bass, Berry & Sims PLC

Healthcare Trends & Transactions Q2 2024

Bass, Berry & Sims PLC on

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing...more

Ankura

Will Regulatory Scrutiny Impact Private Equity Investment in Healthcare?

Ankura on

Private Equity in Healthcare - Over the past decade, private equity investors have shown a particular interest in acquiring or investing in various healthcare providers and services. This includes physician practices across...more

Goodwin

Indiana Enacts Broad Notification Requirements for Healthcare Transactions with a Clear Focus on Private Equity

Goodwin on

Earlier this year, Indiana joined a growing number of states by enacting a new notification requirement for certain healthcare transactions. Indiana Senate Bill Number 9 (SB 9), effective July 1, 2024, is likely to require...more

McDermott Will & Emery

HPE Miami 2023 | Getting Tactical: What Healthcare Investment Bankers Think

McDermott Will & Emery on

During this session, Partner David Ivill moderated a panel featuring investment bankers at leading financial institutions that discussed the big economic themes they predict for the year ahead, particularly as they impact...more

McDermott Will & Emery

[Event] 2023 J.P. Morgan Healthcare Conference - January 10th, San Francisco, CA

Come together with key decision-makers, innovators and investors from across the healthcare, life sciences and private equity (PE) industries during the year’s largest healthcare investment symposium....more

McDermott Will & Emery

[Event] 2022 Life Sciences Dealmaking Symposium & Investment Forum - April 28th - 29th, Boston, MA

McDermott Will & Emery on

At the Life Sciences Dealmaking Symposium and Investment Forum, seasoned dealmakers, investors industry executives and technical experts will join McDermott's leading transactional, venture financing and private equity...more

Morgan Lewis

Global Healthcare Series: How COVID-19 Impacted Healthcare Transactions in the Asia Pacific

Morgan Lewis on

The year 2020 saw a wave of healthcare activity in the Asia Pacific region. Buyouts rose to a record high of 156 deals in 2020, up from 68 in 2019. Disclosed value reached a new peak of $16.9 billion compared with $11 billion...more

McGuireWoods LLP

Investing in the Future: 2021 Digital Health Trends for Private Equity Investors

McGuireWoods LLP on

Technology is affecting the way healthcare is delivered daily — and health technology, focused on facilitating and enabling healthcare functions, is creating new opportunities for private equity investors....more

Goodwin

Global Trends and Opportunities in Life Sciences Real Estate – Spotlighting the U.S. and the UK

Goodwin on

An aging global population, a once-in-a-century pandemic and the continued convergence of scientific breakthroughs like cell and gene therapies and artificial intelligence are among just a few of the key factors that continue...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: TA Associates and Francisco Partners Invest in Edifecs

McGuireWoods LLP on

TA Associates and Francisco Partners have signed a definitive agreement to make a significant growth investment in Edifecs, according to a news release....more

McDermott Will & Emery

[Event] 3rd Annual Shanghai Life Sciences Forum - November 12th, Shanghai, China

McDermott Will & Emery on

MWE China Law Offices and its strategic alliance partner McDermott Will & Emery are proud to co-host our annual Shanghai Life Sciences Forum in partnership with the Redefining Early Stage Investments (RESI) conference. This...more

McDermott Will & Emery

[Event] 2019 Healthcare Litigation, Compliance & Investigations Forum - November 5th, Washington, DC

McDermott Will & Emery on

Healthcare industry business, legal and compliance executives and investors will learn strategies for proactively managing and effectively responding to compliance risks, investigations and litigation at our fourth annual...more

McDermott Will & Emery

[Event] 2019 Hospital & Health System Innovation Summit - October 24th, New York, NY

McDermott Will & Emery on

McDermott Will & Emery’s Hospital & Health System Innovation Summit will prepare innovation leadership teams to address the business, regulatory compliance and legal challenges they may face when navigating innovation efforts...more

McDermott Will & Emery

[Event] 2019 Healthcare Services Private Equity Leadership Forum - October 25th, New York, NY

McDermott Will & Emery on

Among the most active markets in private equity, the healthcare industry is ripe with opportunity for players in the healthcare services arena that can navigate the fast-paced deal environment and complex regulatory...more

McDermott Will & Emery

[Event] 2019 European Healthcare Services Private Equity Leadership Forum - September  26th, London, United Kingdom

McDermott’s annual European Healthcare Private Equity Leadership Forum is a must-attend event for executives from top management teams, health and life sciences companies and providers, private equity, family offices,...more

Patterson Belknap Webb & Tyler LLP

Hahnemann University Hospital: Healthcare Bankruptcy Highlights the Tension When Private Equity Collides with the Public Interest

A “little bit of a crisis” was averted last week in the Chapter 11 bankruptcy case of St. Christopher’s Hospital for Children, a Philadelphia-area hospital with ties to Hahnemann University Hospital, which is also a Chapter...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G BioHealth Sells Vertiflex to Boston Scientific

McGuireWoods LLP on

H.I.G. BioHealth Partners, the life-science investment affiliate of H.I.G. Capital, has announced the sale of Vertiflex to Boston Scientific. The total equity value of the sale is approximately $465 million in cash, with...more

Fenwick & West Life Sciences Group

Key Digital Health Investment Trends to Watch

Our fourth annual Digital Health Summit brought together a select group of investors active in the digital health, life sciences, medical device, and healthcare industries for a one-day meeting to discuss the future of...more

19 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide